Sibold William John

Insider profile

Performance

Overall performance
2.6

Performance over holding periods
2.6
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 74% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Sibold William John's trades of Madrigal Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-07-20 2026-07-20 S Sale
13,578 -10.5%
193.23
US$4,281,081
13,578 -10.5% 193.23 US$4,281,081
2026-07-20 2026-07-20 S Sale
10,069 -28.4%
436.25
US$2,580,043
10,069 -28.4% 436.25 US$2,580,043
2026-07-20 2026-07-20 S Sale
22,601 +14.3%
191.86
US$503,650
22,601 +14.3% 191.86 US$503,650
2026-07-20 2026-07-20 S Sale
47 -0.0%
548.87
US$25,797
47 -0.0% 548.87 US$25,797
2026-07-20 2026-07-20 S Sale
680 -0.3%
547.70
US$372,435
680 -0.3% 547.70 US$372,435
2026-07-20 2026-07-20 S Sale
269 -0.1%
547.08
US$147,164
269 -0.1% 547.08 US$147,164
2026-07-20 2026-07-20 S Sale
275 -0.1%
545.71
US$150,070
275 -0.1% 545.71 US$150,070
2026-07-20 2026-07-20 S Sale
545 -0.3%
544.71
US$296,869
545 -0.3% 544.71 US$296,869
2026-07-20 2026-07-20 S Sale
110 -0.1%
543.79
US$59,817
110 -0.1% 543.79 US$59,817
2026-07-20 2026-07-20 S Sale
140 -0.1%
542.75
US$75,984
140 -0.1% 542.75 US$75,984
2026-07-20 2026-07-20 PrS Proposed sale
2,500
553.48
US$1,383,700
2,500 553.48 US$1,383,700
2026-03-06 2026-03-06 S Sale
1,663 -1.0%
431.94
US$718,316
1,663 -1.0% 431.94 US$718,316
2026-03-06 2026-03-06 PrS Proposed sale
1,663
439.34
US$730,622
1,663 439.34 US$730,622
2026-01-26 2026-01-26 PrS Proposed sale
1,577
480.45
US$757,670
1,577 480.45 US$757,670
2026-01-26 2026-01-26 S Sale
1,577 -1.1%
492.42
US$776,546
1,577 -1.1% 492.42 US$776,546
2025-12-04 2025-12-04 PrS Proposed sale
2,400
579.89
US$1,391,736
2,400 579.89 US$1,391,736
2025-12-04 2025-12-04 S Sale
2,400 -1.6%
575.34
US$1,380,816
2,400 -1.6% 575.34 US$1,380,816
2025-09-09 2025-09-09 PrS Proposed sale
7,279
453.80
US$3,303,210
7,279 453.80 US$3,303,210
2025-09-09 2025-09-09 S Sale
7,279 -6.6%
445.63
US$3,243,741
7,279 -6.6% 445.63 US$3,243,741
2025-08-21 2025-08-21 PrS Proposed sale
7,616
391.66
US$2,982,883
7,616 391.66 US$2,982,883
2025-08-21 2025-08-21 PlS Planned sale
1,131 -1.0%
401.00
US$453,531
1,131 -1.0% 401.00 US$453,531
2025-08-21 2025-08-21 PlS Planned sale
6,485 -5.5%
400.03
US$2,594,225
6,485 -5.5% 400.03 US$2,594,225
2025-01-27 2025-01-24 S Sale
1,584 -2.8%
335.24
US$531,020
1,584 -2.8% 335.24 US$531,020
2025-01-24 2025-01-24 PrS Proposed sale
1,584
340.14
US$538,782
1,584 340.14 US$538,782
2024-09-11 2024-09-09 S Sale
6,363 -10.2%
243.83
US$1,551,490
6,363 -10.2% 243.83 US$1,551,490
2024-09-10 2024-09-09 PrS Proposed sale
6,363
243.83
US$1,551,514
6,363 243.83 US$1,551,514